Explore Products
Primary Cells

Human Mantle Cell Lymphoma Peripheral Blood Mononuclear Cells (Relapsed/Refactory)

  • BSL

    1

  • 133
Mantle Cell Lymphoma Peripheral Blood Mononuclear Cells are density separated by Ficoll-Paque from Mantle Cell Lymphoma peripheral blood. Mantle Cell Lymphoma PBMCs are available in untreated and relapsed/refractory stages.
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options
Species

Human

Cat.No

ABC-TC3890

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Product Category Primary Cells
Size/Quantity

1 vial

Cell Type

Mononuclear Cell

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Mantle Cell Lymphoma

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Diseased Human Peripheral Blood Mononuclear Cells

Description

Human Mantle Cell Lymphoma Peripheral Blood Mononuclear Cells (Relapsed/Refractory) are derived from peripheral blood samples of patients with relapsed/refractory mantle cell lymphoma (MCL). Morphological analysis shows that this cell population mainly consists of atypical small lymphocytes, and its immunophenotype displays typical MCL features: Cyclin D1 and CD5 are diffusely and positively expressed, while SOX-11 is positive in some cases. The combination of these three markers provides a crucial basis for diagnosis.Its core genetic feature is the t(11;14)(q13;q32) chromosomal translocation, which leads to abnormal overexpression of the cyclin D1 (CCND1) gene, thereby driving the cell cycle out of control.Additionally, these cells exhibit persistent abnormal activation of the B cell receptor (BCR) signaling pathway, significantly enhancing tumor B cell survival by continuously activating downstream pathways such as PI3K/AKT and MAPK.

View Product Image

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

  • Human Mantle Cell Lymphoma Peripheral Blood Mononuclear Cells (Relapsed/Refactory) can be used for high-throughput screening and efficacy verification of targeted drugs (such as BTK inhibitors, PI3K inhibitors), as well as sensitivity assessment of new immunotherapies (CAR-T, dual antibodies). In addition, these cells can also be used for drug resistance mechanism research and biomarker discovery to predict treatment response or relapse, including TP53 mutations and epigenetic changes.

Inquiring Human Mantle Cell Lymphoma Peripheral Blood Mononuclear Cells (Relapsed/Refactory)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button